Purpose: We examined the role of smoking in the two dimensions behind the time trends in adult mortality in European countries: i.e., rectangularization of the survival curve (mortality compression) and longevity extension (increase in the age at death).
INTRODUCTION
Smoking is a well-known determinant not only of individual health (e.g. (1, 2) ), but also of population-level mortality rates and trends over time, especially in high-income countries.
Smoking has a strong influence on the ranking of countries by life expectancy (3), sex differences in mortality (4) (5) (6) , and variations in mortality trends between countries and sexes (e.g. (3, 7, 8) ). The impact of smoking on mortality at the population level is an important research field with considerable relevance for a range of health-related policies.
Most previous studies on the role smoking plays in mortality variations over time and between countries have examined life expectancy or overall mortality (3, 6, 7) . Recently, however, there has been a shift in mortality research away from looking at life expectancy alone-i.e., the expected average age at death-towards taking into account the full age-at-death distributions.
To describe the changes over time, two scenarios have been distinguished which actually operate in tandem to increase life expectancy: first, a decline in premature mortality with no increase in the maximum lifespan, which results in more people dying at the same ages and a compressed age-at-death distribution ("mortality compression" or "rectangularization of the survival curve")(9); and, second, a delay in ageing, which manifests itself in increases in the lifespan and in the number of centenarians (here referred to as "longevity extension") (e.g.(10)). The relative roles of the two processes in the mortality trend are currently under debate, but are important for the future development of life expectancy. If only "rectangularization" occurs, we would be approaching a limit to life expectancy. If, however, "longevity extension" occurs, it is unlikely that a life expectancy limit will be reached in the near future.
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A C C E P T E D ACCEPTED MANUSCRIPT 4 Previous literature within the compression of mortality debate has focused on describing the changes in the age-at-death distribution and the survival curves through different mortality indicators (e.g., variability in age at dying), rather than on offering empirical explanations for these changes. When an explanation has been provided, it has tended to refer primarily to international differences in age-at-death variability (11) (12) (13) (14) (15) (16) (17) (18) (19) , rather than to the various trends over time (11, 13, 16, 20, 21) . Smoking has, however, been mentioned as being one of the possible determinants of differences in age-at-death variability between countries, sexes, or educational groups (e.g. (12, 14, 18) ). Moreover, Hill (1993) (22) We examined the role of smoking in both of the processes underlying the trends in adult mortality in 10 European countries over the period 1950 to 2009 simultaneously; i.e., the rectangularization of the survival curve (compression of mortality) and longevity extension (increase in the age at death). Our paper generates relevant information on how smoking affects trends in the full age-at-death distribution, and contributes to the current debate on the compression of mortality.
METHODS

Study design and population
M A N U S C R I P T
A C C E P T E D ACCEPTED MANUSCRIPT 5 We employed an ecological study which uses national mortality data by sex for 10 lowmortality, high-income European countries: Denmark, Finland, France, West Germany, Italy, the Netherlands, Norway, Sweden, Switzerland, and the United Kingdom. As we were restricted by the availability of the lung cancer mortality data needed for our approach, we studied only northern and western European countries from 1950 to 2009.
Changes in adult survival
To study changes in survival after age 50, period life table data were obtained from the Human Mortality Database (www.mortality.org). Using the approach developed by Rousson & Paccaud (2010) (23, 24) , we assessed trends in (i) trimmed life expectancy (tLE_50), calculated by excluding the 10% of deaths at the highest ages to get more stable indicators (25); (ii) rectangularity; and (iii) longevity. Rectangularity (R) represents the area under the survival curve divided by the area of the smallest rectangle containing that curve. The higher the R, the more rectangular the survival curve. Longevity (L) is the age at which survival from age 50 equals 10%. Subsequently, tLE_50 = R * (L-50).
We decomposed the gain in tLE_50 between 1950 and 2009 into the contribution of rectangularization (first term) and longevity extension (second term), as:
comparing the trends in the indicators for all-cause mortality with those for non-smoking-related mortality; and (iii) comparing the relative contributions of rectangularization and longevity extension in the gains in life expectancy over time for all-cause mortality and non-smokingrelated mortality.
Lifetime smoking prevalence and non-smoking-related mortality were estimated using an adapted version of the indirect Peto-Lopez method (26, 27) . The methodology uses lung cancer mortality but also takes into account the effect of smoking on other causes of death. The countryand sex-specific lung cancer deaths by five-year age groups (up to 80+) were obtained through WHOSIS (http://www.who.int/whosis/mort/download/en/) and additional national sources. To adjust for lung cancer mortality not due to smoking, the lifetime smoking prevalence (p) by sex and five-year age groups were estimated by comparing the obtained lung cancer mortality rates with the smoothed age-and sex-specific lung cancer rates of the smokers and the never-smokers in the ACS CPS-II study (26) . This lifetime smoking prevalence reflects the smoking prevalence about 30 years earlier and the risk of lung cancer mortality associated with this prevalence, which is strongly related to the dose consumed. To enable us to compare the lifetime smoking prevalence levels in different countries, we calculated for each country and sex an age-and sex standardized average, using the population of the United Kingdom in 2009 as the standard population.
The survival curve for non-smoking related mortality was estimated through the age-specific mortality probabilities for non-smoking-related mortality, which were obtained by multiplying the age-specific mortality probabilities for all-cause mortality with one minus the age-specific smoking-attributable mortality fractions (= the share of all-cause mortality due to M A N U S C R I P T A C C E P T E D ACCEPTED MANUSCRIPT 7 smoking)(SAF). The SAFs were calculated by applying the age-and sex-specific relative risks (RRs) of dying from smoking for all-cause mortality to the lifetime smoking prevalence (p) using the formula SAF = p(RR-1)/(p(RR-1)+1). The RRs were obtained from the ACS CPS-II study (26) , and were subsequently smoothed by applying a second-degree polynomial. To take into account residual confounding and to obtain conservative estimates, the RRs were adjusted downwards by reducing the excess risk by 30% (28) . (27) The obtained SAFs by five-year age groups were turned into single-year values by a least squares linear regression which applied the SAF for age 80+ to the single ages 83-110+. Focusing first on all-cause mortality, we can see an overall increase in all indicators, and more regularly for women than for men. The gain in tLE_50 was between 3.4 and 9.3 years. The increase in rectangularity and longevity reflect a decline in premature mortality after age 50 and a decline in old-age mortality, respectively. The two-segment regression lines (dotted lines) The trends over in indirectly estimated age-and sex-standardized lifetime smoking prevalence clearly differed between men and women ( Figure 2 ). Among men, the high initial levels continued to rise up to around 1980, and began to decline thereafter. Among women, lifetime smoking prevalence was still almost zero in 1950, but started to increase between 1950 and 1980. The increases in prevalence levels were greatest among women in the Netherlands, Denmark, and the United Kingdom, but have stagnated in recent years.
RESULTS
Among men, in most of the countries studied, the timing of the decline in lifetime smoking prevalence ( Figure 2 ) was in line with the acceleration of rectangularization in all-cause mortality (Figure 1; Supplementary figure 1 ). This kind of correspondence is less visible among women.
To investigate this relationship in greater depth, we calculated trends over 10 years (1950-1960, 1951-1961, …, 1999-2009 ) for each indicator, using slopes of regression lines. We then correlated these trends in lifetime smoking prevalence with the trends in both rectangularity and longevity across the 10-year periods and countries, by sex (see Figure 3 ). Among men, the Spearman correlation between the trends in lifetime smoking prevalence and the trends in rectangularity were strongly negative (-0.82). The correlation was less negative between the trends in lifetime smoking prevalence and the trends in longevity (-0.62). Among women, the correlations were weaker, but again stronger for rectangularity (-0.40) than for longevity (-0.13).
The trends in the survival curve indicators were more linear for non-smoking-related mortality than for all-cause mortality (Figure 1; Supplementary figure 1 ), especially among men. For nonsmoking-related mortality no sudden acceleration in rectangularization occurred among men in most of the countries around 1980. Among women, the accelerations in rectangularization for non-smoking-related mortality were weaker than for all-cause mortality in most of the countries, whereas for longevity clear differences were uncovered for Denmark and the United Kingdom only.
For both all-cause mortality and non-smoking-related mortality, the contribution of rectangularization (LEAR) to the overall gain in tLE_50 between 1959 and 2009 was consistently less than 50%, which indicates that longevity extension contributed more of the years gained ( Figure 4 ). But among men, LEAR was lower for non-smoking-related mortality (around 30%) than for all-cause mortality (around 40%). Among women, LEAR was almost the same for all-cause and non-smoking-related mortality, at around 40%.
DISCUSSION
Our results suggest that smoking affects rectangularization of the survival curve more than longevity extension. Trends in lifetime smoking prevalence correlated negatively with both rectangularization and longevity extension, but more negatively with rectangularization. The Our observation that smoking affects rectangularity more than longevity is, at first glance, more obvious among men than among women. This is likely due to the higher levels of smoking prevalence and the more important changes in smoking prevalence among men than among women, which we can also see from the trends in lifetime smoking prevalence. When women started smoking a couple of decades after men, their smoking prevalence levels were lower because the negative effects of smoking were already well known (8).
Nonetheless, we found clear similarities between the sexes in the ways in which smoking affected rectangularization relative to longevity extension. In Figure 3 , women and men are in similar portions of the plot. The lower correlation observed among women seems mainly attributable to the absence of negative trends and many near-zero trends among women.
Additional analysis which excluded trends calculated over years in which the lifetime smoking prevalence was under 10% resulted in fairly similar results for men and women: a correlation of -0.82 among men and of -0.63 among women between trends in lifetime smoking prevalence and trends in rectangularity; and of -0.62 and -0.40, respectively, between trends in lifetime smoking prevalence and trends in longevity (see Supplementary figure 2 ).
Moreover, in Denmark, the United Kingdom, Germany, the Netherlands, Norway, Sweden, and Switzerland, where the smoking prevalence among women was large enough to result in a sizeable difference between all-cause and non-smoking related mortality, this difference was larger for rectangularity than for longevity, as also observed among men.
Although in general smoking was found to be more important for rectangularization than for longevity extension, a few countries, and particularly the Netherlands, exhibited more similar patterns in longevity extension between men and women for non-smoking-related mortality than M A N U S C R I P T
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12 for all-cause mortality. This could indicate that smoking can have an influence even on old-age mortality, especially in terms of sex differences in mortality (7,32). These similarities were particularly large for the period up to 1980, resulting in a small remaining overall sex difference, largely explained by biological factors. The more positive non-smoking-related mortality trends among women than among men from 1980 onwards, observed as well in other countries, are most likely the result of behavioural factors again (5, 33) .
It should be noted that we assessed the role of smoking indirectly. An advantage of using an indirect method rather than relying on the scarcely available smoking prevalence data is that it allows us take into account the different dimensions of smoking, including the dose consumed.
Therefore these indirect methods are often used (e.g. (34) ). The crucial assumptions of the Peto- Out of the many indicators which could be used to study the rectangularization of the survival curve or the compression of mortality (40)(11), we chose to assess rectangularization using the approach by Rousson & Paccaud (2010) (24) , which follows the "moving rectangle" principle introduced by Wilmoth and Horiuchi (11). Although our method excluded 10% of deaths at the highest ages to obtain stable indicators, among its advantages is the fact that the method's indicators can be easily calculated and combined to allow for the decomposition of a change in life expectancy (24) . A sensitivity analysis which used the proportion of the area under the survival curve in a rectangle drawn up to age 100 as the rectangularity indicator resulted in similar conclusions.
Wilmoth and Horiuchi (11) showed a high correlation between the moving rectangle measure and various measures of the variability in the age-at-death distribution (such as the interquartile range). It should be noted, however, that although measures of rectangularization are often interpreted in practice as being measures of variability, there are scenarios in which we can have rectangularization of the survival curve without necessarily having a reduction in variability in the age-at-death distribution.
In conclusion, our analysis has clearly shown that smoking affects rectangularization more than longevity extension, which is likely due to the fact that smoking kills a substantial proportion of people at relatively young ages. Despite large differences in the extent of the smoking epidemic among men and women, clear similarities between the sexes exist in the ways in which smoking affects rectangularization relative to longevity extension.
Male life expectancy-and particularly survival from premature mortality-would have been substantially higher if smoking had not reached epidemic proportions among men in high-
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14 income countries during the 20th century. Since the smoking epidemic has not yet reached its peak among women, we can expect that female life expectancy-and especially female survival from premature mortality-will be lower than its potential level for some time to come.
The important effects of smoking on past mortality trends, and particularly the resulting nonlinear trends in rectangularization, need to be considered when predicting future mortality. 
